Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Cert. of designation
Appointed director
|
|
Bionik Laboratories Corp. (BNKL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/27/2015 |
8-K
| Asset disposition|
Docs:
|
"Bionik Laboratories Raises $6.2 Million Toronto, Ontario -- February 27, 2015 -- Bionik Laboratories Corp. , a Delaware corporation , announced today that it acquired Bionik Laboratories, Inc., a Toronto corporation , and completed the sale to qualified accredited investors of units consisting of its common stock and warrants for aggregate gross proceeds of approximately $6.2 million. Shares of the Company's common stock will continue to be quoted on the OTC Markets under the symbol “DWTPD” until FINRA’ s approval of the ticker “BNKL.” Bionik Laboratories is an innovative medical-robotics company that develops healthcare solutions for patients with restricted physical mobility. Peter Bloch, CEO of Bionik Laboratories, stated, “Our team at Bionik Labs is focused and dedicated to deploying c..." |
|
|
|